Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $54.53 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $40.09 | 2 | $0 (2023) |
| Nestle HealthCare Nutrition Inc. | $14.44 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.86 | 1 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($19.86) |
| 2022 | $34.67 | 2 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($20.23) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/28/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Gastroenterology | ||||||
| 08/31/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, PLENVU | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Gastroenterology | ||||||
| 08/15/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 13 | $2,366 | $759.96 |
| 2022 | 1 | 32 | 35 | $6,370 | $2,012 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 13 | $2,366 | $759.96 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 20 | $3,640 | $1,230 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 15 | $2,730 | $781.65 | 28.6% |
About Emily Turner
Emily Turner is a Addiction (Substance Use Disorder) healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2021. The National Provider Identifier (NPI) number assigned to this provider is 1528636370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Emily Turner has received a total of $54.53 in payments from pharmaceutical and medical device companies, with $19.86 received in 2023. These payments were reported across 3 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($54.53).
As a Medicare-enrolled provider, Turner has provided services to 44 Medicare beneficiaries, totaling 48 services with total Medicare billing of $2,772. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Addiction (Substance Use Disorder)
- Other Specialties Medical, Adult Health
- Location Rochester, NY
- Active Since 06/16/2021
- Last Updated 07/17/2023
- Taxonomy Code 163WA0400X
- Entity Type Individual
- NPI Number 1528636370
Products in Payments
- XIFAXAN (Drug) $40.09
- ZENPEP (Drug) $14.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Addiction (Substance Use Disorder) Doctors in Rochester
Mr. Douglas Newcomb, Lcsw-R, Casac, Mpa, LCSW-R, CASAC, MPA
Addiction (Substance Use Disorder)
Mr. Gary Wolk, Lcsw-R, Casac, Cgp, LCSW-R, CASAC, CGP
Addiction (Substance Use Disorder)
Thomas Cormican, Licsw, LICSW
Addiction (Substance Use Disorder)
Mrs. Patricia Kelsey, Lcsw, Casac, LCSW, CASAC
Addiction (Substance Use Disorder)
Mr. Peter Teall, Lcsw-R, Casac, LCSW-R, CASAC
Addiction (Substance Use Disorder)
Masahiko Sato, Edd, Lmft, Lpcc, EDD, LMFT, LPCC
Addiction (Substance Use Disorder)